These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 9704451)
41. Use of current generation perfluorocarbon emulsions in cardiac surgery. Holman WL; McGiffin DC; Vicente WV; Spruell RD; Pacifico AD Artif Cells Blood Substit Immobil Biotechnol; 1994; 22(4):979-90. PubMed ID: 7849969 [TBL] [Abstract][Full Text] [Related]
42. [Dynamics of arterial pressure and gas exchange in dogs with acute blood loss replaced by an emulsion of carbon tetrafluoride]. Akhsianov UU; Afonin NI; Troitskiĭ VB Gematol Transfuziol; 1983 Apr; 28(4):41-4. PubMed ID: 6852512 [No Abstract] [Full Text] [Related]
43. Modeling of oxygen transport in blood-perfluorocarbon emulsion mixtures: Part I: oxygen uptake in tubular vessels. Patel S; Mehra A ASAIO J; 1998; 44(3):144-56. PubMed ID: 9617943 [TBL] [Abstract][Full Text] [Related]
48. The structure-property correlation: estimates of the half-clearance time of perfluororganic compounds. Golovanov IB; Ivanitskii GR; Tsygankova IG; Khabarova MI Dokl Biochem; 2000; 371(1-6):63-8. PubMed ID: 10853453 [No Abstract] [Full Text] [Related]
49. Amphiphilic sugar phosphates with single or double perfluoroalkylated hydrophobic chains for use in oxygen and drug delivery systems. Guillod F; Greiner J; Milius A; Riess JG Artif Cells Blood Substit Immobil Biotechnol; 1994; 22(4):1273-9. PubMed ID: 7849933 [TBL] [Abstract][Full Text] [Related]
50. Which is the foreseeable clinical application of oxygen-carrying blood substitutes (fluorocarbons and hemoglobin solutions)? Which impact are they likely to have on the activity of blood services? Vox Sang; 1982 Feb; 42(2):97-109. PubMed ID: 7064434 [No Abstract] [Full Text] [Related]
51. Modeling of oxygen uptake in perfluorocarbon emulsions. Some comparisons with uptake by blood. Shah N; Mehra A ASAIO J; 1996; 42(3):181-9. PubMed ID: 8725685 [TBL] [Abstract][Full Text] [Related]
52. Microparticle, nanoparticle, and stem cell-based oxygen carriers as advanced blood substitutes. Tao Z; Ghoroghchian PP Trends Biotechnol; 2014 Sep; 32(9):466-73. PubMed ID: 24929580 [TBL] [Abstract][Full Text] [Related]
54. Synthetic oxygen transport fluids based on perfluorochemicals: applications in medicine and biology. Lowe KC Vox Sang; 1991; 60(3):129-40. PubMed ID: 1862635 [TBL] [Abstract][Full Text] [Related]
55. Carbohydrate- and related polyol-derived fluorosurfactants: an update. Riess JG; Greiner J Carbohydr Res; 2000 Jul; 327(1-2):147-68. PubMed ID: 10968680 [TBL] [Abstract][Full Text] [Related]
56. Red cell substitutes: an update. Gould SA; Sehgal LR; Rosen AL; Sehgal HL; Moss GS Ann Emerg Med; 1985 Aug; 14(8):798-803. PubMed ID: 4025972 [TBL] [Abstract][Full Text] [Related]
57. [Oxygen supply of the body during the administration organofluorine emulsions (a pathophysiological analysis)]. Iarochkin VS; Koziner VB Patol Fiziol Eksp Ter; 1988; (3):81-6. PubMed ID: 3050820 [No Abstract] [Full Text] [Related]
58. On the perfluorocarbon emulsions of second generation. Meinert H; Fackler R; Knoblich A; Mader J; Reuter P; Röhlke W Biomater Artif Cells Immobilization Biotechnol; 1992; 20(1):95-113. PubMed ID: 1617088 [TBL] [Abstract][Full Text] [Related]